Hannah joined the CRF-UCC in 2020 as a clinical trials monitor, joining from her role in the quality department of Rowa Pharmaceuticals.

Previously, Hannah has worked for Eli Lilly in the Clinical Trial Capabilities department.

Hannah has a BSc Hons in Genetics from UCC and is currently completing a MSc in Precision Cancer Medicine with the University of Oxford.

Hannah takes an active role in PPI and participates in a number of groups within the HSE R&D group as a PPI representative.